Micelles have been studied as drug delivery carriers for decades. Their use can potentially
result in high drug accumulation at the target site through the enhanced permeability and …

Triple-negative breast cancer (TNBC) shows a higher response rate to systemic therapy
compared with other breast cancer subtypes. However, the tumor differentiation of TNBC is …

Breast cancer accounts for 25% of all types of cancer in women, and triple negative breast
cancer (TNBC) comprises around 15~ 20% of breast cancers. Conventional chemotherapy …

Triple negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC) are amongst
the most aggressive forms of solid tumors. TNBC is highlighted by absence of genetic …

Polymeric micelles have acquired quite an interest as an innovative drug delivery system for
the diagnosis and treatment of breast cancer, as they endeavour numerous benefits over the …

Although neuroendocrine tumors (NETs) are slow growing, they are frequently metastatic at
the time of discovery and no longer amenable to curative surgery, emphasizing the need for …

Polymeric micellar drug carriers have emerged as effective tools to enhance the solubility
and bioavailability of hydrophobic drugs. These micelles possess a nano size structure that …

Transferrin receptor (TfR) is a promising target validated in the clinical trials for managing
various malignancies. Transferrin (Tf) and single chain antibody fragment can target TfR and …

Breast cancer is the most common malignancy and a leading cause of cancer-related
mortality among women worldwide. Triple-negative breast cancer (TNBC) is characterized …

The journey of chemotherapeutic drugs from the site of administration to the site of action is
confronted by several factors including low bioavailability, uneven distribution in major …